Deep Intelligence Across Industries

Company Headquarters: Japan Founded: 2003 Workforce: ~50 Company Working: Human Metabolome Technologies America Inc. is a biotechnology company in capillary electrophoresis-mass spectrometry (CE-MS)-based metabolome analysis. The company operates through two segments— metabolome analysis and biomarker. The metabolome analysis segment provides analysis services used to analyze and measure metabolomics samples. The biomarker segment involved in the exploration of biomarkers, and the R&D of in vitro diagnostic drugs and equipment. The pharmaceutical, biotech, and food industry are the key customers of the company and use these products for drug discovery and diagnosis purpose. Geographically the company is located in the Americas, Europe, and Japan.

Company Headquarters: Morrisville, US Founded: 2000 Workforce: ~200 Company Working: Metabolon, Inc. is a leading diagnostic service provider company which offers customized and scalable metabolomics solutions used in research and product development by biopharma, academic research sectors, and biotech companies. Under its metabolomics platform, the company provides different products which are used in biological understandings of disease state and biological reactions in the present time. The company specializes in biomarkers, metabolomics, diagnostic tests, and clinical study design.

Company Headquarters: New York, US Founded: 2004 Workforce: ~200 Company Working: Creative Proteomics, an integrated biotech contract research organization (CRO), is involved in providing a full range of drug development services which includes metabolomics, glycomics, proteomics, and bioinformatics analysis services used for research in the biotechnology, pharmaceutical, nutrition, and agriculture industries, and in some cases used by academic and government organizations. The company specializes in protein identification, protein quantification, metabolomics service, protein gel, and imaging analysis, protein post-translational modification analysis, and lipidomics service.

Company Headquarters: Austria Founded: 2003 Workforce: ~50 Company Working: Biocrates Life Sciences AG (Biocrates) is a global solution provider for metabolomics services. In addition to metabolomics services, the company is engaged in developing clinical biomarker assays and quality control assays to advance clinical study outcomes. The product offered by the company such as Biocrates biomarkers focuses on diagnostic of diabetes, early diagnosis of pancreatic cancer (PDAC), congestive heart failure (CHF), kidney disease, sepsis, stroke, and various types of cancer such as ovarian and breast cancer.

Company Headquarters: Alberta, Canada Founded: 2011 Workforce: ~51-200 Company Working: TMIC (The Metabolomics Innovation Centre) is a nationally-funded core facility. It has an exceptional blend of infrastructure and employees to accomplish a wide range of cutting-edge metabolomic studies for clinical trials research, bioproducts studies, nutrient profiling biomedical studies, and environmental testing. It offers a diverse set of technologies for targeted, quantitative, and untargeted metabolomics using nuclear magnetic resonance (NMR), gas chromatography-mass spectrometry (GC-MS), liquid chromatography-mass spectrometry (LC-MS), ultra-performance liquid chromatography (UPLC), high-performance liquid chromatography (HPLC), and metabolite imaging. TMIC is widely spread, fee-for-service, university-based core facility providing quantitative metabolomics services for Canada’s public and private research sectors.

Company Headquarters: Sydney, Australia Founded: 2006 Workforce: ~ 11-50 Company Working: Digital Medics Pty Ltd (Digital Medics) offers innovative SmartPlus Digital Insulin Pen and the Diabetes IQ App for better diabetes care and control. Digital Medics Pty Ltd is the international representative for the SmartPlus insulin pen in Australia under the approval of the Therapeutic Goods Administration (TGA) in Australia.

Company Headquarters: Potsdam, Germany Founded: 2008 Workforce: ~51-100 Company Working: Emperra GmbH E-Health Technologies is a research and development-driven medical technology start-up company. It offers innovative concepts and solutions in the fields of e-health technologies and telediabetology. In its Esysta system, the company is known for combining innovative software with future-oriented hardware such as the first digitally connected insulin pen. The Esysta system is available and reimbursed in Germany. The company’s diabetic care product line is used for tracking, monitoring, and transmission of diagnostic and therapeutic data of diabetic patients such as insulin doses, blood sugar levels, and carbohydrates.

Company Headquarters: Seoul, South Korea Founded: 2004 Workforce: ~30-50 Company Working: Diamesco Co., Ltd (Diamesco) is a Korean healthcare company, which discovers, develops, manufactures, and markets products for insulin delivery devices. The company offers insulin pens, pen needles, digital insulin pen, insulin pump sets, insulin syringe, and accessories in the global market. The company focuses on offering products for diabetes treatment. The firm has a direct and indirect presence in more than 20 countries across the globe. The company has a strong presence in Asia-Pacific and Europe.

Company Headquarters: California, US Founded: 2013 Workforce: ~51-200 Company Working: Companion Medical is a leader in the development of innovative solutions & advanced technology for the management of diabetes. It is the first company to received US Food and Drug Administration (FDA) approval for InPen, a smart insulin pen used to improve diabetes care. The InPen system is consists of a Bluetooth-enabled pen that is connected to an app that offers dose reminders for patients. The company offers its products in the treatment of Type 1 and Type 2 diabetes. The firm has a strong presence in North America and Europe.